These data suggest that LTD inhibits the progression of synovial inflammation in RA by promoting the activation of STAT6 signals, and plays the role of inhibiting pro-inflammatory factors and activating anti-inflammatory factors. This evidence concerns the gene STAT6 and rheumatoid arthritis.